No Data
No Data
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Why Astrazeneca (AZN) Is a Top Growth Stock for the Long-Term
Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kirin, AstraZeneca, Mitsubishi Tanabe Pharma, Genentech, Amgen, GlaxoSmithKline, Boehringer Ingelheim
According to DelveInsight's analysis, the growth of the systemic sclerosis market is expected to be mainly driven by increasing prevalence, patient awareness, and the launch of potential therapies wi
Express News | Germany supports the public to receive the vaccine jointly developed by Astrazeneca and Sanofi for respiratory syncytial virus (RSV), but currently does not support vaccination with Pfizer's vaccine.
GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca
New York, USA, June 26, 2024 (GLOBE NEWSWIRE) -- GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer